Meningococcal Group Y Oligosaccharide Conjugated To Corynebacterium Diphtheriae Crm197 Protein, N. Meningitidis Group C (Strain C11) Polysaccharide Conjugated Crm197, N. Meningitidis Group A Oligosaccharide Conjugated Crm197, N. Meningitidis Group W135 Oligosaccharide Conjugated Crm197, Recombinant Neisseria Meningitidis Group B Nhba Fusion Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide, Recombinant Neisseria Meningitidis Group B Nada Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide, Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide, Outer Membrane Vesicles (Omv) From Neisseria Meningitidis Group B Strain Nz98/254 Measured As Amount Of Total Protein Containing The Pora P1.4 Adsorbed On Aluminium Hydroxide

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →
2 Registered trials
0 Recruiting
2 Completed trials
1 Sponsors
3 Countries
Phase II: 1 Phase I/II: 1

Indications tested

Meningitis meningococcal 2

Sponsors using this IMP

GlaxoSmithKline Biologicals 2

All trials

2 total

Showing 1–2 of 2 trials

← All drugs A–Z